ArticleScientific reports2026
Indirect screening for paternal perinatal depression independent of maternal factors using mother-reported EPDS-partner in a community-based cohort in Japan.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Paternal perinatal depression negatively affects maternal mental health and child development. However, early detection remains limited, particularly in countries such as Japan, where paternal involvement in perinatal care is low. The Edinburgh Postnatal Depression Scale-Partner (EPDS-P), a maternal-rated tool for screening paternal depression, offers a feasible solution. This study longitudinally evaluated the screening performance of the EPDS-P from the prenatal to postpartum periods and examined its independence from maternal psychological and demographic characteristics. This prospective, community-based cohort study in Towada, Japan, included couples assessed during home visits by public health nurses and midwives. Elevated paternal depressive symptoms were defined as a Center for Epidemiologic Studies Depression Scale score ≥ 16. Receiver operating characteristic curves were used to evaluate discriminatory accuracy, and multivariable analyses were used to assess the association of maternal and paternal age, parity, gestational weeks or postpartum days, and maternal Edinburgh Postnatal Depression Scale and Mother-to-Infant Bonding Scale scores. Data from 385 prenatal and 411 postpartum couples were analyzed. The EPDS-P demonstrated fair discriminatory accuracy (area under the curve: 0.783, prenatal; 0.746, postpartum). The prenatal and postpartum selected decision thresholds (3 and 4, respectively) achieved sensitivities of 70.7% and 61.5% and specificities of 75.9% and 86.8%, respectively. The EPDS-P score assessed paternal perinatal depression while remaining largely independent of maternal factors. Its integration into routine perinatal care may help identify at-risk fathers in settings with limited paternal engagement and contribute to more inclusive, family-centered mental health support.Clinical trial number: This study protocol was registered with the University Hospital Medical Information Network-Clinical Trials Registry: UMIN-CTR ( https://www.umin.ac.jp/ctr/ ) on September 28, 2021 (Trial registration number: UMIN000045584). UMIN-CTR has been recognized by the International Committee of Medical Journal Editors (ICMJE) as an “acceptable registry.”
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.